Influence of branched-chain amino acids and branched-chain keto acids on protein synthesis in isolated hepatocytes
Open Access
- 1 March 1987
- journal article
- research article
- Published by Wolters Kluwer Health in Hepatology
- Vol. 7 (2) , 324-329
- https://doi.org/10.1002/hep.1840070218
Abstract
We investigated the effects of the branched-chain amino acids—valine, leucine and isoleucine—or their keto analogs, the branched-chain keto acids—α-ketoisovaleric acid, α-ketoisocaproic acid and α-keto-β-methylvaleric acid—on protein synthesis and secretion by monolayers of rabbit hepatocytes incubated with [35S] methionine in pulse-chase and steady-state experiments. The branched-chain amino acids (2.0 mM or 1.0 mM), in the presence or absence of insulin (2 × 10−4 IU per dish) and in both types of experiments, reduced the trichloroacetic acid-precipitable 35S-protein secreted into the medium. The branched-chain keto acids (2.0 mM or 1.0 mM) had a stimulatory effect on secreted trichloroacetic acid-precipitable 35S-protein which was observed only by the pulse-chase technique in the presence of insulin. Immunoaffinity chromatography of medium demonstrated a slight inhibition by branched-chain amino acids and a slight stimulation by branched-chain keto acids on secretion of 35S-albumin and no effect of either treatment on secretion of 35S-fibrinogen. ELISA analysis of total (i.e., 35S-labeled and unlabeled) secreted albumin revealed an inhibitory effect of the branched-chain amino acids in both pulse-chase and steady-state experiments, and a small stimulatory effect, in steady-state experiments, of the branched-chain keto acids; both effects were insulin-dependent. Total secreted fibrinogen, under steady-state conditions, was increased by the branched-chain keto acids in the presence of insulin, while transferrin production was unaffected by any treatment. Intracellular trichloroacetic acid-precipitable 35S-protein was increased by the branched-chain keto acids in the presence of insulin and was reduced by the branched-chain amino acids in the presence or absence of insulin, suggesting that the effects of these agents may have been related to synthesis and not to effects on secretion.This publication has 36 references indexed in Scilit:
- Disease‐Specific Amino Acid Infusion (F080) in Hepatic Encephalopathy: A Prospective, Randomized, Double‐Blind, Controlled TrialJournal of Parenteral and Enteral Nutrition, 1985
- Branched chain amino acid therapy in liver disease.Journal of the American College of Nutrition, 1985
- Comparison of Dietary Protein with an Oral, Branched Chain-Enriched Amino Acid Supplement in Chronic Portal-Systemic Encephalopathy: A Randomized Controlled TrialHepatology, 1984
- Therapeutic Aspects of Branched-Chain Amino and Keto AcidsClinical Science, 1984
- Is Intravenous Administration of Branched Chain Amino Acids Effective in the Treatment of Hepatic Encephalopathy? A Multicenter StudyHepatology, 1983
- Total Parenteral Nutrition with F080® in Cirrhotics with Subclinical EncephalopathyAnnals of Surgery, 1983
- Branched-chain amino acids in the treatment of chronic hepatic encephalopathy.Gut, 1982
- Branched-chain amino acids vs lactulose in the treatment of hepatic comaDigestive Diseases and Sciences, 1982
- The mechanism of hepatic coma†Hepatology, 1981
- The Use of Amino Acid Precursors in Nitrogen-Accumulation DiseasesNew England Journal of Medicine, 1974